« Previous
Next »
American Journal of Kidney Diseases
Volume 45, Issue 4
, Pages 788-789
, April 2005
Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression
References
- . Immunosuppressive treatment for idiopathic membranous nephropathy (A systematic review) . Am J Kidney Dis . 2004;44:385–401
- . Idiopathic membranous nephropathy (Definition and relevance of a partial remission) . Kidney Int . 2004;66:1199–1205
- . The treatment of idiopathic membranous nephropathy (A dilemma or a conundrum?) . Am J Kidney Dis . 2004;44:562–566
-
.
Glomerular Diseases
(The American College of Physicians Nephrology Medical Knowledge Self Assessment Program (MKSAP))
. Philadelphia, PA: American College of Physicians-American Society of Internal Medicine; 1998;
- A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy . Kidney Int . 1995;48:1600–1604
- . Management of glomerular proteinuria (A commentary) . J Am Soc Nephrol . 2003;14:3217–3232
- . Validation of a predictive model of idiopathic membranous nephropathy (Its clinical and research implications) . Kidney Int . 1997;51:901–907
- Cyclosporine in patients with steroid-resistant membranous nephropathy (A randomized trial) . Kidney Int . 2001;59:1484–1490
- Mycophenolate therapy of SLE membranous nephropathy . Kidney Int . 2004;66:2411–2415
- . Rituximab for idiopathic membranous nephropathy . Lancet . 2002;360:923–924
Originally published online as doi:10.1053/j.ajkd.2005.01.033 on February 28, 2005.
PII: S0272-6386(05)00133-2
doi: 10.1053/j.ajkd.2005.01.033
© 2005 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
American Journal of Kidney Diseases
Volume 45, Issue 4
, Pages 788-789
, April 2005
